BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 91629)

  • 1. Effects of delta 1-tetrahydrocannabinol on cyclic AMP in cultured human diploid fibroblasts.
    Kelly LA; Butcher RW
    J Cyclic Nucleotide Res; 1979; 5(4):303-13. PubMed ID: 91629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of delta 1-tetrahydrocannabinol (THC) on cyclic AMP metabolism in cultured human fibroblasts.
    Kelly LA; Butcher RW
    Prog Clin Biol Res; 1979; 27():227-36. PubMed ID: 218231
    [No Abstract]   [Full Text] [Related]  

  • 3. The escape of cyclic AMP from human diploid fibroblasts: general properties.
    Kelly LA; Wu C; Butcher RW
    J Cyclic Nucleotide Res; 1978 Dec; 4(6):423-35. PubMed ID: 85640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The turnover of cyclic AMP in cultured fibroblasts.
    Barber R; Butcher RW
    J Cyclic Nucleotide Res; 1980; 6(1):3-14. PubMed ID: 6155391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins and cannabis XIV. Tolerance to the stimulatory actions of cannabinoids on arachidonate metabolism.
    Burstein S; Hunter SA; Renzulli L
    J Pharmacol Exp Ther; 1985 Oct; 235(1):87-91. PubMed ID: 2995649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of astrocytoma cells in the presence of prostaglandin E1: effect on the regulation of cyclic AMP metabolism.
    Leichtling BH; Drotar AM; Ortmann R; Perkins JP
    J Cyclic Nucleotide Res; 1976; 2(2):89-97. PubMed ID: 177468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cyclic nucleotide phosphodiesterase in the inhibition of cyclic AMP accumulation by carbachol and phosphatidate.
    Nemecek GM; Honeyman TW
    J Cyclic Nucleotide Res; 1982; 8(6):395-408. PubMed ID: 6193153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGE1-independent MDCK cells have elevated intracellular cyclic AMP but retain the growth stimulatory effects of glucagon and epidermal growth factor in serum-free medium.
    Taub M; Devis PE; Grohol SH
    J Cell Physiol; 1984 Jul; 120(1):19-28. PubMed ID: 6203919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of FSH-stimulated cAMP accumulation by delta 9-tetrahydrocannabinol in cultured rat granulosa cells.
    Treinen KA; Sneeden JL; Heindel JJ
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):53-7. PubMed ID: 8381567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
    Dill JA; Howlett AC
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1157-63. PubMed ID: 2855242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic effect of prostaglandin E1 in Swiss 3T3 cells: role of cyclic AMP.
    Rozengurt E; Collins MK; Keehan M
    J Cell Physiol; 1983 Sep; 116(3):379-84. PubMed ID: 6193130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.
    Burstein S; Hunter SA; Ozman K
    Mol Pharmacol; 1983 Jan; 23(1):121-6. PubMed ID: 6865895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP does not modulate hexose uptake of serum-deprived BHK-21 fibroblasts.
    Lavis VR; Davenport R; Pontier P; Thompson WJ; Strada SJ
    J Cell Physiol; 1982 Sep; 112(3):373-5. PubMed ID: 6182151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
    Jeon YJ; Yang KH; Pulaski JT; Kaminski NE
    Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
    Hillard CJ; Harris RA; Bloom AS
    J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.